Wplyw ogolnodostepnych preparatow wspomagajacych odchudzanie - karnityny, chitosanu i guarany - na organizm czlowieka

• Autorzy: Gromadzka-Ostrowska J , Dworznicki J
• Języki publikacji: PL

Słowa kluczowe

PL

zdrowie czlowieka; chitozan; choroby czlowieka; guarana; otylosc; karnityna; preparaty odchudzajace; odchudzanie; suplementacja zywnosci

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2001
• Tom: 28
• Numer: 4
• Opis fizyczny: s.351-359,bibliogr.

Twórcy

autor

Gromadzka-Ostrowska J

• Katedra Dietetyki i Żywności Funkcjonalnej, Zakład Fizjologii Żywienia, Wydział Nauk o Żywieniu Człowieka i Konsumpcji, Szkola Glowna Gospodarstwa Wiejskiego, Warszawa

autor

Dworznicki J

• Katedra Dietetyki i Żywności Funkcjonalnej, Zakład Fizjologii Żywienia, Wydział Nauk o Żywieniu Człowieka i Konsumpcji, Szkola Glowna Gospodarstwa Wiejskiego, Warszawa

Bibliografia

• 1. Atkinson R.L., Blank R.C., Loper J.F.: Combined drug treatment of obesity. Obes. Res., 1995, 3, Suppl. 4, 497S.
• 2. Belliardo F., Martelli A., Valle M.G.: HPLC determination of caffeine and theophylline in Paullinia cupana (Guarana) and Cola spp. samples. Z. Lebensm. Unters. Forsch., 1985, 180, 398.
• 3. Bempong D.K., Houghton P.J.: Dissolution and absorption of caffeine from guarana. J. Pharm. Pharmacol., 1992, 44, 769.
• 4. Bentkowski Z.: Karnityna - witaminopodobna substancja odżywcza. Nowa era zastosowań klinicznych. Warszawa, Sunmed, 1997.
• 5. Brass E.P., Hiatt W.R.: Minireview: carnitine metabolism during exercise. Life Sci., 1994, 54, 1383.
• 6. Bremer J.: The role of carnitine in cell metabolism. In: Carnitine Today. Ed.: C. de Simone, G. Famularo Austin, Landes Bioscience, p. 1, 1997.
• 7. Carlson M., Thompson R.D.: Liquid chromatographic determination of methylxanthines and catechins in herbal preparations containing guarana. J. Am. Obes. Assoc. Inter., 1998, 81, 691.
• 8. Cerretelli P., Marconi C.: L-carnitine supplementation in humans. The effects on physical performance. Int. J. Sports Med., 1990, 11, 1.
• 9. Daly P.A., Krieger D.R., Dulloo A.G.: Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity. Int. J. Obes., 1993, 17, Suppl. 1, S73.
• 10. Davis A.T., Davis P.G., Phinney S.D.: Plasma and urinary carnitine of obese subjects on very-low- calorie diet. J. Am. Coll. Nutr., 1990, 9, 261.
• 11. Dendai B.S.: Effect of caffeine on the metabolism of rats exercising by swimming. Braz. J. Med. Biol. Res., 1994, 27, 2481.
• 12. Deuchi K., Kanauchi O., Imasato Y., Kobayashi E.: Decreasing effect of chitosan on the apparent fat digestibility by rats fed on high-fat diet. Biosci. Biotech. Biochem., 1994, 58, 1613-1616.
• 13. Deuchi K., Kanauchi O., Imasato Y., Kobayashi E.: Effect of viscosity or deacylation degree of Chitosan on fecal fat excreated from rats fed on a high-fat diet. Biosci. Biotech. Biochem., 1995, 59, 781.
• 14. Deuchi K., Kanauchi O., Shizukuishi M., Kobayashi E.: Continous and massive intake of chitosan affects mineral and fat-soluble vitamin status in rats fed on a high-fat diet. Biosci. Biotech. Biochem., 1995, 59, 1211-1216.
• 15. Dulloo A.G.: Ephedrine, xanthine and prostaglandin-inhibitors: actions and interactions in the stimulation of thermogenesis. Int. J. Obes., 1993, 17, Suppl. 1, S35.
• 16. Dulloo A.G., Seydoux J., Girardier L.: Green tea and thermogenesis: interactions between catechin-polyphenols, caffeine and sympathetic activity. Int. J. Obes. Relat. Metab. Dis., 2000, 24, 252.
• 17. Dyck D.J.: Dietary fat intake, supplements and weight loss (Review). Can. J. App. Physiol., 2000, 25, 495.
• 18. Espaniola E.B., Dias R.F., Mattei R.: Pharmacological activity of guarana in laboratory animals. J. Ethnophar., 1997, 55, 223.
• 19. Evans E.M., Saunders M.J., Spano M.A.: Body-composition changes with diet and exercise in obese women: a comparison of estimates from clinical methods and a 4-component model. Am. J. Clin. Nutr., 1999, 70, 5.
• 20. Fogelholm M., Kukkonen-Harjula K., Nenonen A.: Effect of walking training on weight maintenance after a very-low-energy diet in premenopausal obese women: a randomized controlled trail. Arch. Int. Med., 2000, 160, 2177.
• 21. Föhrenbach R., März W., Lohrer H., et al.: The influence of L-carnitine on lipid metabolism in athletes. Deutsche Zeitsc. Sportmed., 1993, 44, 349.
• 22. Furda I.: Reduction of absorption of dietary lipids and cholesterol by chitosan and its derivatives and special formulation. In: Chitosan per os from dietary supplement to drug carrier. Ed.: R.A. Muzzarelli. Italy, Atec Edizioni, 41-63, 2000.
• 23. Gardin J.M., Schumacher D., Constantine K.D. et al.: Valvularabnormalities and cardiovascular status following exposure to dexfenfluramine or fenfluramine. J. Am. Med. Assoc., 2000, 283, 1703-1709.
• 24. Gatti R., De Palo C.B., Spinella P., De Palo E.F.: Free carnitine and acetyl carnitine plasma levels and their relatioship with body muscular mass in athletes. Amino Acids 1998, 14, 361.
• 25. Gromadzka-Ostrowska J., Dworznicki J.: Wpływ suplementacji diety redukcynej na wybrane wskaźniki lipidowe i hormonolne u ludzi z nadwagą i otyłością (przygotowywane do druku).
• 26. Guercioloni R., Radu-Radulescu L., Boldrin M., et al.: Comparative eveluation of fecal fat excretion induced by Orlistat and chitosan. Obesity Res., 2001, 9, 363- 367.
• 27. Han L.K., Kimura Y., Okuda H.: Reduction in fat storage during chitin- chitosan treatment in mice fed a high fat diet. Inter. J. Obes. Relat. Metab. Dis., 1999, 23, 174.
• 28. Hawley J.A., Brouns F., Jeukendrup A.: Strategies to enhance fat utilization during exercise (Review). Sports Med, 1998, 25, 241.
• 29. Heo K., Odle J., Han I.K.: Dietary L-carnitine improves nitrogen utilization in growning pigs fed low energy, fat-containing diets. J. Nutr., 2000, 130, 1809.
• 30. Hongu N., Sachan D.S.: Caffeine, carnitine and choline supplementation of rats decreased body fat and serum leptin concentration as does exercise. J. Nutr, 2000, 130, 152.
• 31. Jacob C., Belleville F.: L-carnitine: metabolisme, functions et interet en pathologie. Pathol. Biol., Paris 1992, 9, 910.
• 32. Kaats G.R., Wise J.A., Blum K., et al.: The short-term therapeutic efficacy of treating obesity with a plan of improved nutrition and moderate caloric restriction. Curr. Therap. Res., 1992, 51, 261.
• 33. Kato H., Taguchi T., Obuda H.: Antihypertensive effect of chitosan in rats and humans. J. Trad. Med., 1994, 11, 198.
• 34. Krotkiewski M.: Otyłość - środki wspomagające w dietetycznej i farmakologicznej terapii. Przew. Lek. 2002, 6, 78-88.
• 35. LeHoux J.G., Grondin F.: Some effects of chitosan on liver function in the rat. Endocrinology, 1993, 132, 1078.
• 36. Lengsfeld H., Fleury A., Noite M.: Effects of Orlistat and chitosan on faecal fat excretion in young healthy volunteers. Obesity Res., 1999, 7, Suppl. 1, 132.
• 37. Marconi C., Sassi G., Carpinelli A., et al.: Effects of L-carnitine loading on the aerobic and anerobic performance of endurance athletes. Eur. J. Appl. Physiol., 1985, 54, 131.
• 38. Mattei R., Dias R.F., Espinola E.B.: Guarana: toxic behavioral effects in laboratory animals and antioxidants activity in vitro. J. Ethnophar., 1998, 60, 111.
• 39. McCann U.D., Sciden L.S., Rubin L.J., Ricaurte G.A.: Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence. J. Am. Med. Assoc., 1997, 278, 666-672.
• 40. McCarty M.F.: Utility of metformin as an adjunct to hydroxycitrate/carnityne for reducing body fat in diabetics. Med. Hypothesis 1998, 51, 399.
• 41.Mitchell M.E.: Carnitine metabolism in human subjects. Values of carnitine in biological fluids and tissues of normal subjects. Am. J. Clin. Nutr., 1978, 31, 481.
• 42. Miura T., Tatara M., Nakamura K., Suzuki I.: Effect of guarana on exercise in normal nad epinephrine-induced glycogenolytic mice. Biol. Pharm. Bull., 1998, 21, 646.
• 43. Morelli V., Zoorob R.J.: Alternative therapies: Part I. Depression, diabetes, obesity. Am. Family Physican., 2000, 62, 1051.
• 44. Peluso G., Petillo O., Raqnieri M., et al.: Chitosan-mediated stimulation of macrophage function. Biomaterials 1994, 15, 1215.
• 45. Pittler M.H., Abbot N.C., Harkness E.F.: Randomized, double-blind trial of chitosan for body weight reduction. Europ. J. Clin. Nutr., 1999, 53, 379.
• 46. Rebouche C.J., Engel A.G.: Tissue distribution of carnitine biosynthetic enzyme in man. Biochem. Biophys. Acta 1980, 630, 22.
• 47. Rebouche C.J., Bosch E.P., Chenard C.A., et al.: Utilization of dietary precursors for carnitine synthesis in human adults. J. Nutr., 1989, 19, 1907.
• 48. Rebouche C.J., Seim H.: Carnitine metabolism and its regulation in microorganisms and mammals. Annu. Rev. Nutr., 1998, 18, 39.
• 49. Rodriguez M.S., Albertengo L.E., Agullo E.: Emulsification capacity and hydrolipidemic effect of chitosan. In: Chitosan per os from dietary supplement to drug carrier. Ed.: R.A. Muzzarelli, Italy. Atec Edizioni 77-94, 2000.
• 50. Ross R., Janssen I., Tremblay A.: Obesity reduction through lifestyle modification. Can. J. Appl. Physiol., 2000, 25, 1.
• 51.Santa Maria A., Lopez A., Diaz M.M.: Evaluation of the toxicity of guarana with in vitro bioassays. Ecotoxi. Environ. Safety 1998, 39, 164.
• 52. Schiller R.N., Barrager R.D., Schauss A.G., Nichols E.J.: A randomized, double blind, placebo-controlled study examining the effects of a rapidly soluble chitosan dietary supplement on weight loss and body composition in overweight and mildly obese individuals. J. Am. Nutraceutical Assoc., 2001, 4, 10-17.
• 53. Siliprandi N., Venerando R., Tassani V.: The “carnitine system”: recent aspects. Adv. Exp. Med. Biol., 1994, 368, 161.
• 54. Sugano M., Watanabe S., Kishi A., et al.: Hypocholesterolemic action of chitosan with different viscosity in rats. Lipids 1988, 23, 187.
• 55. Terada A., Hara H., Sato D.: Effect of dietary chitosan on faecal microbiota and faecal metabolites of humans. Microb. Ecol. Health Dis., 1995, 8, 15-21.
• 56. Villiani R.G., Gannon J., Self M.: L-carnitine supplementation combined with aerobic training does not promote weight loss in moderately obese women. Int. J. Sport Nutr. Exer. Metab., 2000, 10, 199.
• 57. Wuolijoki E., Hirvela T., Ylitalo P.: Decrease in serum LDL cholesterol with microcrystalline chitosan. Met. Find. Exp. Clin. Pharm., 1999, 21, 357.